Pilot study of baricitinib for active Sjogren’s syndrome

Saved in:
Bibliographic Details
Published inAnnals of the rheumatic diseases Vol. 81; no. 7; pp. 1050 - 1052
Main Authors Bai, Wei, Liu, Huilan, Dou, Lei, Yang, YunJiao, Leng, XiaoMei, Li, Mengtao, Zhang, Wen, Zhao, Yan, Zeng, Xiaofeng
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd and European League Against Rheumatism 01.07.2022
Elsevier Limited
Subjects
Anemia
Arteritis
Arthritis
Autoimmune diseases
Azetidines - therapeutic use
Case reports
Clinical trials
Coronaviruses
COVID-19
CXCL10 protein
Cytopenia
Dermatomyositis
Ethics
Exocrine glands
Fever
Hemoglobin
Hepatitis B
Hepatitis B surface antigen
Hospitals
Humans
Hydroxychloroquine
Immunoglobulin G
Immunological diseases
Immunology
Interleukin 12
Interleukin 17
Interleukin 23
Janus kinase
Janus kinase 2
Laboratories
Letter
Liver
Lung diseases
Medical schools
Nervous system
Pandemics
Patients
Pilot Projects
Polymyalgia rheumatica
Purines - therapeutic use
Pyrazoles
Rheumatoid arthritis
Rheumatology
Sjogren's syndrome
Sjogren's Syndrome - drug therapy
Sulfonamides
therapeutics
γ-Interferon
autoimmune diseases
therapeutics
sjogren's syndrome
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Correspondence-2
content type line 23
ISSN:0003-4967
1468-2060
1468-2060
DOI:10.1136/annrheumdis-2021-222053